Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Efficacy and safety of autologous stem cell transplantation after induction therapy with lenalidomide, bortezomib, and dexamethasone.

Arcani R, Venton G, Colle J, Suchon P, Ivanov V, Mercier C, Farnault L, Roche P, Lafage M, Brunet C, Azouza W, Pourroy B, Fanciullino R, Costello R.

Eur J Haematol. 2019 Jul 18. doi: 10.1111/ejh.13297. [Epub ahead of print]

PMID:
31319001
2.

A Nucleophilic Gold(III) Carbene Complex.

Pujol A, Lafage M, Rekhroukh F, Saffon-Merceron N, Amgoune A, Bourissou D, Nebra N, Fustier-Boutignon M, Mézailles N.

Angew Chem Int Ed Engl. 2017 Sep 25;56(40):12264-12267. doi: 10.1002/anie.201706197. Epub 2017 Aug 24.

PMID:
28782276
3.

[MALDI-TOF mass spectrometry: Evaluation of the preanalytical phase for identification of molds].

Maldonado I, García Ramírez D, Striebeck P, Lafage M, Fernández Canigia L.

Rev Argent Microbiol. 2017 Jan - Mar;49(1):7-14. doi: 10.1016/j.ram.2016.10.001. Epub 2017 Feb 9. Spanish.

4.

Phosphorus-stabilized titanium carbene complexes: synthesis, reactivity and DFT studies.

Lafage M, Heuclin H, Le Goff XF, Saffon-Merceron N, Mézailles N.

Chemistry. 2014 Dec 15;20(51):16995-7003. doi: 10.1002/chem.201403708. Epub 2014 Oct 22.

PMID:
25339253
5.

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.

Beldjord K, Chevret S, Asnafi V, Huguet F, Boulland ML, Leguay T, Thomas X, Cayuela JM, Grardel N, Chalandon Y, Boissel N, Schaefer B, Delabesse E, Cavé H, Chevallier P, Buzyn A, Fest T, Reman O, Vernant JP, Lhéritier V, Béné MC, Lafage M, Macintyre E, Ifrah N, Dombret H; Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL).

Blood. 2014 Jun 12;123(24):3739-49. doi: 10.1182/blood-2014-01-547695. Epub 2014 Apr 16.

6.

14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma.

Cosson A, Chapiro E, Belhouachi N, Cung HA, Keren B, Damm F, Algrin C, Lefebvre C, Fert-Ferrer S, Luquet I, Gachard N, Mugneret F, Terre C, Collonge-Rame MA, Michaux L, Rafdord-Weiss I, Talmant P, Veronese L, Nadal N, Struski S, Barin C, Helias C, Lafage M, Lippert E, Auger N, Eclache V, Roos-Weil D, Leblond V, Settegrana C, Maloum K, Davi F, Merle-Beral H, Lesty C, Nguyen-Khac F; Groupe Francophone de Cytogénétique Hématologique.

Genes Chromosomes Cancer. 2014 Aug;53(8):657-66. doi: 10.1002/gcc.22176. Epub 2014 Apr 12.

PMID:
24729385
7.

Interference with the PTEN-MAST2 interaction by a viral protein leads to cellular relocalization of PTEN.

Terrien E, Chaffotte A, Lafage M, Khan Z, Préhaud C, Cordier F, Simenel C, Delepierre M, Buc H, Lafon M, Wolff N.

Sci Signal. 2012 Aug 14;5(237):ra58. doi: 10.1126/scisignal.2002941.

8.

PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies.

Duhoux FP, Ameye G, Montano-Almendras CP, Bahloula K, Mozziconacci MJ, Laibe S, Wlodarska I, Michaux L, Talmant P, Richebourg S, Lippert E, Speleman F, Herens C, Struski S, Raynaud S, Auger N, Nadal N, Rack K, Mugneret F, Tigaud I, Lafage M, Taviaux S, Roche-Lestienne C, Latinne D, Libouton JM, Demoulin JB, Poirel HA; Groupe Francophone de Cytogénétique Hématologique (GFCH); Belgian Cytogenetic Group for Haematology and Oncology (BCG-HO).

Br J Haematol. 2012 Jan;156(1):76-88. doi: 10.1111/j.1365-2141.2011.08918.x. Epub 2011 Nov 3.

PMID:
22050763
9.

Peptides targeting the PDZ domain of PTPN4 are efficient inducers of glioblastoma cell death.

Babault N, Cordier F, Lafage M, Cockburn J, Haouz A, Prehaud C, Rey FA, Delepierre M, Buc H, Lafon M, Wolff N.

Structure. 2011 Oct 12;19(10):1518-24. doi: 10.1016/j.str.2011.07.007.

10.

Amplification of the G allele at SNP rs6983267 in 8q24 amplicons in myeloid malignancies as cause of the lack of MYC overexpression?

Micale L, Augello B, Daniele G, Macchia G, L'abbate A, Muehlematter D, Vandenberghe P, Johansson B, Cabrol C, Solé F, Dastugue N, Slovak ML, Lillington D, Raynaud S, Lafage M, Nacheva ED, Merla G, Storlazzi CT.

Blood Cells Mol Dis. 2011 Dec 15;47(4):259-61. doi: 10.1016/j.bcmd.2011.09.001. Epub 2011 Sep 25. No abstract available.

PMID:
21945030
11.

The type I interferon response bridles rabies virus infection and reduces pathogenicity.

Chopy D, Detje CN, Lafage M, Kalinke U, Lafon M.

J Neurovirol. 2011 Aug;17(4):353-67. doi: 10.1007/s13365-011-0041-6. Epub 2011 Jul 30.

PMID:
21805057
12.

Ambivalent role of the innate immune response in rabies virus pathogenesis.

Chopy D, Pothlichet J, Lafage M, Mégret F, Fiette L, Si-Tahar M, Lafon M.

J Virol. 2011 Jul;85(13):6657-68. doi: 10.1128/JVI.00302-11. Epub 2011 Apr 27.

13.

Chromosomal abnormalities in transformed Ph-negative myeloproliferative neoplasms are associated to the transformation subtype and independent of JAK2 and the TET2 mutations.

Nguyen-Khac F, Lesty C, Eclache V, Couronné L, Kosmider O, Andrieux J, Collonge-Rame MA, Penther D, Lafage M, Bilhou-Nabera C, Chapiro E, Mozziconacci MJ, Mugneret F, Gachard N, Nadal N, Lippert E, Struski S, Dastugue N, Cabrol C, Bernard OA; Groupe Francophone de Cytogénétique Hématologique.

Genes Chromosomes Cancer. 2010 Oct;49(10):919-27. doi: 10.1002/gcc.20802.

PMID:
20629097
14.

Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein.

Préhaud C, Wolff N, Terrien E, Lafage M, Mégret F, Babault N, Cordier F, Tan GS, Maitrepierre E, Ménager P, Chopy D, Hoos S, England P, Delepierre M, Schnell MJ, Buc H, Lafon M.

Sci Signal. 2010 Jan 19;3(105):ra5. doi: 10.1126/scisignal.2000510.

15.

Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias.

Couronné L, Lippert E, Andrieux J, Kosmider O, Radford-Weiss I, Penther D, Dastugue N, Mugneret F, Lafage M, Gachard N, Nadal N, Bernard OA, Nguyen-Khac F.

Leukemia. 2010 Jan;24(1):201-3. doi: 10.1038/leu.2009.169. Epub 2009 Aug 27. No abstract available.

PMID:
19710701
16.

Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies.

Ménager P, Roux P, Mégret F, Bourgeois JP, Le Sourd AM, Danckaert A, Lafage M, Préhaud C, Lafon M.

PLoS Pathog. 2009 Feb;5(2):e1000315. doi: 10.1371/journal.ppat.1000315. Epub 2009 Feb 27.

17.

Presence of a minor Philadelphia-positive clone in young adults with de novo T-cell ALL.

Prebet T, Mozziconacci MJ, Sainty D, Arnoulet C, Lafage M, Dastugue N, Charbonnier A, Coso D, Gastaut JA, Blaise D, Vey N.

Leuk Lymphoma. 2009 Mar;50(3):485-7. doi: 10.1080/10428190802601148. No abstract available.

PMID:
19197723
18.

Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.

Graux C, Stevens-Kroef M, Lafage M, Dastugue N, Harrison CJ, Mugneret F, Bahloula K, Struski S, Grégoire MJ, Nadal N, Lippert E, Taviaux S, Simons A, Kuiper RP, Moorman AV, Barber K, Bosly A, Michaux L, Vandenberghe P, Lahortiga I, De Keersmaecker K, Wlodarska I, Cools J, Hagemeijer A, Poirel HA; Groupe Francophone de Cytogénétique Hématologique; Belgian Cytogenetic Group for Hematology and Oncology.

Leukemia. 2009 Jan;23(1):125-33. doi: 10.1038/leu.2008.278. Epub 2008 Oct 16.

PMID:
18923437
19.

Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis.

Lafon M, Mégret F, Meuth SG, Simon O, Velandia Romero ML, Lafage M, Chen L, Alexopoulou L, Flavell RA, Prehaud C, Wiendl H.

J Immunol. 2008 Jun 1;180(11):7506-15.

20.

Erratum to: The Innate Facet of the Brain: Human Neurons Express TLR3 and Sense Viral dsRNA.

Lafon M, Megret F, Lafage M, Prehaud C.

J Mol Neurosci. 2007 Oct;33(2):224. doi: 10.1007/s12031-007-0068-6. No abstract available.

PMID:
29349718
21.

Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections.

Mégret F, Prehaud C, Lafage M, Moreau P, Rouas-Freiss N, Carosella ED, Lafon M.

Hum Immunol. 2007 Apr;68(4):294-302. Epub 2006 Dec 28.

22.

The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA.

Lafon M, Megret F, Lafage M, Prehaud C.

J Mol Neurosci. 2006;29(3):185-94. Erratum in: J Mol Neurosci. 2007;33(2):224. J Mol Neurosci. 2007 Oct;33(2):224.

PMID:
17085778
23.

Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experience.

Picard C, Hayette S, Bilhou-Nabera C, Cayuela JM, Delabesse E, Frenoy N, Preudhomme C, Dupont M, Bastard C, Bories D, Vaerman JL, Davi F, Dastugue N, Raynaud S, Lafage M, Deschaseaux F, Fest T, Gaub MP, Lhéritier V, Thomas X, Charrin C, Boucheix C, Dombret H, Macintyre E, Fière D, Gabert J.

Leukemia. 2006 Dec;20(12):2178-81. Epub 2006 Oct 12. No abstract available.

PMID:
17039237
24.

Modulation of HLA-G expression in human neural cells after neurotropic viral infections.

Lafon M, Prehaud C, Megret F, Lafage M, Mouillot G, Roa M, Moreau P, Rouas-Freiss N, Carosella ED.

J Virol. 2005 Dec;79(24):15226-37.

25.

Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon.

Préhaud C, Mégret F, Lafage M, Lafon M.

J Virol. 2005 Oct;79(20):12893-904.

26.

Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosis.

Mégret F, Prehaud C, Lafage M, Batejat C, Escriou N, Lay S, Thoulouze MI, Lafon M.

Vaccine. 2005 Nov 16;23(46-47):5342-50. Epub 2005 Jul 18.

27.

The benefit of induction chemotherapy in patients age > or = 75 years.

Vey N, Coso D, Bardou VJ, Stoppa AM, Braud AC, Bouabdallah R, Sainty D, Mozziconacci MJ, Lafage M, Damaj G, Blaise D, Gastaut JA, Maraninchi D.

Cancer. 2004 Jul 15;101(2):325-31.

28.

Apoptosis inversely correlates with rabies virus neurotropism.

Thoulouze MI, Lafage M, Yuste VJ, Kroemer G, Susin SA, Israel N, Lafon M.

Ann N Y Acad Sci. 2003 Dec;1010:598-603.

PMID:
15033799
29.

Autologous stem cell transplantation for acute myelogenous leukemia in first complete remission: a 6-year follow-up study of 101 patients from a single institution.

Vey N, Bouabdallah R, Stoppa A, Faucher C, Lafage M, Chabannon C, Sainty D, Gastaut J, Maraninchi D, Blaise D.

Bone Marrow Transplant. 2004 Jan;33(2):177-82.

PMID:
14647259
30.

High level of Bcl-2 counteracts apoptosis mediated by a live rabies virus vaccine strain and induces long-term infection.

Thoulouze MI, Lafage M, Yuste VJ, Baloul L, Edelman L, Kroemer G, Israel N, Susin SA, Lafon M.

Virology. 2003 Sep 30;314(2):549-61.

31.

[Normotensive scleroderma renal crisis].

Villaverde M, González A, Orellano P, Lafage M.

Medicina (B Aires). 2003;63(1):49-50. Spanish.

PMID:
12673962
32.

New mechanisms of AML1 gene alteration in hematological malignancies.

Roumier C, Fenaux P, Lafage M, Imbert M, Eclache V, Preudhomme C.

Leukemia. 2003 Jan;17(1):9-16. Review.

PMID:
12529654
33.

Survey of early disapearance of BCR/ABL fusion transcript after allogeneic or autologous stem cell transplantation for chronic myelogenous leukemia.

Vey N, Balatzentko G, Lafage M, Sainty D, Bouabdallah R, Chabannon C, Blaise D, Gastaut JA, Gabert J.

Leuk Lymphoma. 2001 Sep-Oct;42(5):945-52.

PMID:
11697649
35.

Absence of the p55 Kd TNF-alpha receptor promotes survival in rabies virus acute encephalitis.

Camelo S, Lafage M, Lafon M.

J Neurovirol. 2000 Dec;6(6):507-18.

PMID:
11175323
36.

Selective role for the p55 Kd TNF-alpha receptor in immune unresponsiveness induced by an acute viral encephalitis.

Camelo S, Lafage M, Galelli A, Lafon M.

J Neuroimmunol. 2001 Feb 1;113(1):95-108.

PMID:
11137581
37.

Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patients.

Vey N, Blaise D, Lafage M, Olive D, Viens P, Baume D, Camerlo J, Stoppa AM, Gabus R, Brandely M, Hercend T, Maraninchi D.

J Immunother. 1999 Mar;22(2):175-81.

PMID:
10093042
38.

The neural cell adhesion molecule is a receptor for rabies virus.

Thoulouze MI, Lafage M, Schachner M, Hartmann U, Cremer H, Lafon M.

J Virol. 1998 Sep;72(9):7181-90.

39.

Chromosome 8 tetrasomies and pentasomies--a clonal abnormality closely associated with acute monocytic leukaemia.

Lessard M, Herry A, Berthou C, Léglise MC, Abgrall JF, Luquet I, Dastugue N, Duchayne E, Rigal-Huguet F, Lafage M, Sainty D, Reiffers J, Bernard P.

Leuk Lymphoma. 1997 Sep;27(1-2):127-35.

PMID:
9373204
40.

Rabies virus infects mouse and human lymphocytes and induces apoptosis.

Thoulouze MI, Lafage M, Montano-Hirose JA, Lafon M.

J Virol. 1997 Oct;71(10):7372-80.

41.

Early establishment of chimerism in the B and T lymphoid lineages after transplantation of allogeneic mobilized blood cells in leukemic patients.

Chabannon C, Lafage M, Mozziconacci MJ, Faucher C, Maraninchi D, Blaise D.

Transplantation. 1997 Jun 15;63(11):1646-52.

PMID:
9197361
42.

A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignancies.

Vey N, De Prijck B, Faucher C, Stoppa AM, Sainty D, Lafage M, Bouabdallah R, Chabannon C, Camerlo J, Gastaut JA, Maraninchi D, Blaise D.

Bone Marrow Transplant. 1996 Sep;18(3):495-9.

PMID:
8879608
43.

Rabies superantigen as a Vbeta T-dependent adjuvant.

Astoul E, Lafage M, Lafon M.

J Exp Med. 1996 Apr 1;183(4):1623-31.

44.

Effects of sodium fluoride and alendronate on the bone mineral in minipigs: a small-angle X-ray scattering and backscattered electron imaging study.

Fratzl P, Schreiber S, Roschger P, Lafage MH, Rodan G, Klaushofer K.

J Bone Miner Res. 1996 Feb;11(2):248-53.

PMID:
8822349
45.

[Role of phosphorus in hyperparathyroidism secondary to non-dialysed adult chronic renal insufficiency].

Combe C, de Précigout V, Lasseur C, Lafage MH, Blanchetier V, Aparicio M.

Nephrologie. 1996;17(3):149-56. Review. French.

PMID:
9064563
46.

Architectural modifications and cellular response during disuse-related bone loss in calcaneus of the sheep.

Thomas T, Vico L, Skerry TM, Caulin F, Lanyon LE, Alexandre C, Lafage MH.

J Appl Physiol (1985). 1996 Jan;80(1):198-202.

PMID:
8847302
47.

Atypical osteomalacia after 2 year etidronate intermittent cyclic administration in osteoporosis.

Thomas T, Lafage MH, Alexandre C.

J Rheumatol. 1995 Nov;22(11):2183-5.

PMID:
8596168
48.

Activation of human tonsil lymphocytes by rabies virus nucleocapsid superantigen.

Martinez-Arends A, Astoul E, Lafage M, Lafon M.

Clin Immunol Immunopathol. 1995 Nov;77(2):177-84.

PMID:
7586725
49.

Persistence of BCR/ABL mRNA-expressing bone-marrow cells in patients with chronic myelogenous leukemia in complete cytogenetic remission induced by interferon-alpha therapy.

Eberlé F, Toiron Y, Camerlo J, Lafage M, Sainty D, Arnoulet C, Raineri V, Gabert J, Maraninchi D, Mannoni P.

Leuk Lymphoma. 1995 Jun;18(1-2):153-7.

PMID:
8580818
50.

Philadelphia chromosome-negative chronic myeloid leukaemia: a report of 14 new cases.

Costello R, Lafage M, Toiron Y, Brunel V, Sainty D, Arnoulet C, Mozziconacci MJ, Bouabdallah R, Gastaut JA, Maraninchi D, et al.

Br J Haematol. 1995 Jun;90(2):346-52.

PMID:
7794755

Supplemental Content

Loading ...
Support Center